Replies to post #122393 on Biotech Values

[DewDiligence]

Re: Pharma R&D

Here’s a counterpoint to the story in #msg-64637084—although
aggregate pharma R&D expenditures are going down, the number
of drugs in phase-3 is going up. This chart shows the top-10 categories:



Source: http://finance.yahoo.com/news/The-Number-of-Drugs-in-Phase-prnews-318076370.html?x=0&.v=1